Skip to main content
logo
Dr. Reddy's Laboratories Limited (NSE:DRREDDY)
India flag India · Delayed Price · Currency is INR
1,237.30
-25.10 (-1.99%)
Oct 14, 2025, 3:30 PM IST

Dr. Reddy's Laboratories Revenue

Dr. Reddy's Laboratories had revenue of 85.45B INR in the quarter ending June 30, 2025, with 11.37% growth. This brings the company's revenue in the last twelve months to 334.26B, up 15.86% year-over-year. In the fiscal year ending March 31, 2025, Dr. Reddy's Laboratories had annual revenue of 325.54B with 16.61% growth.

Revenue (ttm)
334.26B
Revenue Growth
+15.86%
P/S Ratio
3.08
Revenue / Employee
12.02M
Employees
27,811
Market Cap
1,029.89B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 2025325.54B46.37B16.61%
Mar 31, 2024279.16B33.29B13.54%
Mar 31, 2023245.88B31.49B14.69%
Mar 31, 2022214.39B24.67B13.00%
Mar 31, 2021189.72B15.12B8.66%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Sun Pharmaceutical Industries537.77B
Divi's Laboratories96.52B
Cipla274.80B
Apollo Hospitals Enterprise225.51B
Mankind Pharma129.10B
Zydus Lifesciences236.08B
Fortis Healthcare80.94B
Aurobindo Pharma320.25B
Revenue Rankings

Dr. Reddy's Laboratories News

More News